⌘K

Login Start Free

Home/Filings/4/0001144204-19-042094

4//SEC Filing

KRANZLER JAY D 4

Accession 0001144204-19-042094

CIK 0001644963other

View on SEC.gov Company Profile

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 4:17 PM ET

Size

4.8 KB

Accession

0001144204-19-042094

Insider Transaction Report

Form 4

Period: 2019-08-27

AVENUE THERAPEUTICS, INC.ATXI

Director

Transactions

Award
Common Stock
2019-08-27+10,000→ 74,663 total

Footnotes (1)

[F1]Common Stock vests upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen.

Documents

1 file

4
tv528434_form4.xmlPrimary
FORM 4

Issuer

AVENUE THERAPEUTICS, INC.

CIK 0001644963

Entity typeother

Related Parties

1

filerCIK 0001055666

Filing Metadata

Form type: 4
Filed: Aug 27, 8:00 PM ET
Accepted: Aug 28, 4:17 PM ET
Size: 4.8 KB

View on SEC.gov